Recurrent tuberculosis in the United States and Canada: relapse or reinfection? (Q35914851)

11 August 2017

Recurrent tuberculosis in the United States and Canada: relapse or reinfection? (English)

1 reference

11 August 2017

0 references

0 references

United States of America

1 reference

3

Kevin Schwartzman

1 reference

11 August 2017

Robert M Jasmer

1

1 reference

11 August 2017

Lorna Bozeman

2

1 reference

11 August 2017

M Donald Cave

4

1 reference

11 August 2017

Jussi J Saukkonen

5

1 reference

11 August 2017

Beverly Metchock

6

1 reference

11 August 2017

Awal Khan

7

1 reference

11 August 2017

William J Burman

8

1 reference

11 August 2017

Tuberculosis Trials Consortium

9

1 reference

11 August 2017

language of work or name

English

0 references

publication date

11 October 2004

1 reference

American Journal of Respiratory and Critical Care Medicine

11 August 2017

1 reference

11 August 2017

170

1 reference

11 August 2017

12

1 reference

11 August 2017

1360-1366

1 reference

USPHS Tuberculosis Short-Course Chemotherapy Trial 21: effectiveness, toxicity, and acceptability. The report of final results

11 August 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1081OC

Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1081OC

Recurrence in tuberculosis: relapse or reinfection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1081OC

HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1081OC

IS6110 restriction fragment length polymorphism typing of clinical isolates of Mycobacterium tuberculosis from patients with pulmonary tuberculosis in Madras, south India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1081OC

Tuberculosis recurrences: reinfection plays a role in a population whose clinical/epidemiological characteristics do not favor reinfection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1081OC

Molecular epidemiology study of exogenous reinfection in an area with a low incidence of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1081OC

The incidence of false-positive cultures for Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1081OC

The molecular epidemiology of tuberculosis in New York City: the importance of nosocomial transmission and laboratory error

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1081OC

Pneumococcal meningitis in the intensive care unit: prognostic factors of clinical outcome in a series of 80 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1081OC

Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1081OC

High-resolution minisatellite-based typing as a portable approach to global analysis of Mycobacterium tuberculosis molecular epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1081OC

Evaluation of an intensive intermittent-induction regimen and duration of short-course treatment for human immunodeficiency virus-related pulmonary tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clini

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1081OC

Six-month supervised intermittent tuberculosis therapy in Haitian patients with and without HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1081OC

Risk factors for relapse and acquired rifamycin resistance after directly observed tuberculosis treatment: a comparison by HIV serostatus and rifamycin use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1081OC

Relapse in persons treated for drug-susceptible tuberculosis in a population with high coinfection with human immunodeficiency virus in New York City

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1081OC

Molecular Epidemiology of Tuberculosis among HIV-Infected Persons in Switzerland: A Countrywide 9-Year Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1081OC

A prospective, multicenter study of laboratory cross-contamination of Mycobacterium tuberculosis cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200408-1081OC

10.1164/RCCM.200408-1081OC

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference